Metrex CaviWipes 2.0 (12/Case)

(0)
Regular price
$158.00
Sale price
$158.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

Description

The Metrex CaviWipes 2.0 (12/Case) (#14-1100) is a new and improved CaviWipe that can eliminate a large variety of bacteria and viruses in two minutes. These wipes also qualify for the EPA's rigorous Emerging Viral Pathogen Claim. Includes 160 towelettes per canister, with 12 canisters per case.

Warranty: Until Use/Expiration.

These disinfectant wipes have a powerful efficacy, with the ability to eliminate bacteria, viruses, fungi, and other pathogens in two minutes and under. Given the efficacy, it also qualifies for the EPA's Emerging Viral Pathogens claims, which meets current and future infection prevention methods. These wipes are effective on most non-porous hard surfaces, and can be widely used in a variety of settings, from clinics and hospitals to schools and care centers.

The Metrex CaviWipes 2.0 claims a two-minute efficacy against the following viruses and bacteria:

  • Mycobacterium Bacteria
    • Mycobacterium tuberculosis (TB)
  • Non-Enveloped Viruses
    • Adenovirus Type 2
    • Echovirus Type 11
    • Enterovirus Type 71
    • Human Rotavirus
    • Norovirus
    • Feline Calicivirus

  • Pathogenic Fungi
    • Candida Auris

  • Multi Drug-Resistant Bacteria
    • Carbapenem-resistant Klebsiella pneumoniae (CRKP)
    • Methicillin-Resistant Staphylococcus aureus (MRSA)
    • Multidrug-Resistant Acinetobacter baumannii (MRAB)
    • NDM-1 Enterobacter cloacae
    • Penicillin-Resistant Streptococcus pneumoniae (PRSP)
    • Vancomycin-Intermediate Staphylococcus aureus (VISA)
    • Vancomycin-Resistant Enterococcus faecalis (VRE)

  • Bacteria
    • Acinetobacter baumannii
    • Bordetella pertussis
    • Burkholderia cepacia
    • Enterococcus faecium
    • Escherichia coli O157:H7
    • Klebsiella pneumoniae
    • Legionella pneumophila
    • Micrococcus luteus
    • Moraxella catarrhalis
    • Pseudomonas aeruginosa
    • Salmonella enterica
    • Staphylococcus aureus
    • Stenotrophomonas maltophilia
    • Streptococcus mutans
    • Streptococcus pyogenes

  • Enveloped Viruses
    • Hepatitis B Virus (HBV)
    • Hepatitis C Virus (HCV)
    • Herpes simplex virus Type 1
    • Herpes simplex virus Type 2
    • Human lmmunodeficiency Virus Type 1 (HIV-1)
    • Human orthopneumovirus
    • lnfluenza A virus
    • lnfluenza B virus
    • Measles virus
    • Parainfluenza virus Type 3
    • SARS-Associated Coronavirus
    • SARS-CoV-2

Features

Metrex CaviWipes 2.0 Features

  • Proven effective against SARS-CoV-2 on hard surfaces, and EPA List N Compliant.
  • Effective against over 40 pathogens, including all virus types (enveloped, large and small non-enveloped viruses).
  • Compatible with most hard, non-porous surfaces.
  • Enhanced efficacy, with two-minute universal contact time for bacteria, fungi, and pathogens.

Literature

Open Full Site: mfimedical.com